Decreased Central Nervous System Organized Electrical Activity [PE] - N0000008501
Pharmacologic Class Information
Pharmacologic Code | N0000008501 |
Pharmacologic Name | Decreased Central Nervous System Organized Electrical Activity |
Pharmacologic Uses |
|
Pharmacologic Concept | Physiologic Effects - [PE] |
Pharmacologic Concept Description | This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept. |
NDC Products with Decreased Central Nervous System Organized Electrical Activity
The following table contains 3 products whose active ingredient are classified under the same pharmacologic class Decreased Central Nervous System Organized Electrical Activity [PE].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0054-9628 | Sodium Oxybate | Non-Proprietary Name: Sodium Oxybate | Solution | Oral | Hikma Pharmaceuticals Usa Inc. | ACTIVE | |
68727-100 | Xyrem | Non-Proprietary Name: Sodium Oxybate | Solution | Oral | Jazz Pharmaceuticals, Inc. | ACTIVE | |
68727-150 | Xywav | Non-Proprietary Name: (calcium, Magnesium, Potassium, And Sodium Oxybates) | Solution | Oral | Jazz Pharmaceuticals, Inc. | ACTIVE |